«ΨΥΧΟΛΟΓΙΑ έρευνα & εφαρμογές» Τόμος 1, Τεύχος 3, 2018 ISSN: 2623-3673
Misciagna G, Leoci C, Guerra V, et al. Epidemiology of cholelithiasis in southern
Italy. Part II: Risk factors. Eur J Gastroenterol Hepatol 1996; 8: 585–593
Monto A, Patel K, Bostrom A, Pianko S, Pockros P, McHutchison JG, Wright TL.
Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology 2004;
39: 826–834
Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma.
Gastroenterology 2004; 127(5 Suppl 1): S87–S96
Murray RM, Kendler KS, McGuffin P, Wessely S, Castle DJ (eds). Essential
Psychiatry. 4 th ed. Cambridge University Press, Cambridge: 2008
Nalpas B, Pol S, Thepot V, Zylberberg H, Berthelot P, Brechot C. ESBRA 1997
Award lecture: relationship between excessive alcohol
drinking and viral infections. Alcohol Alcohol 1998; 33: 202–206
Naveau S, Giraud V, Borotto E, et al. Excess weight risk factor for alcoholic liver
disease. Hepatology 1997; 25(1): 108–111
Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M, Hurter D, Nawrocki M,
Kruska L, Hensel F, Petry W, Haussinger D. Prognosis of chronic hepatitis C: results
of a large, prospective cohort study. Hepatology 1998; 28: 1687–1695
Okazaki T, Yoshihara H, Suzuki K, Yamada Y, Tsujimura T, Kawano K, Yamada Y,
Abe H. Efficacy of interferon therapy in patients with chronic hepatitis C. Comparison
between non-drinkers and drinkers. Scand J Gastroenterol 1994; 29: 1039–1043
O’Shea RS, Dasarathy S, McCullough AJ. Practice Guideline Committee of the
American Association for the Study of Liver Diseases, Practice Parameters